Ajmaline

Confirm delete?

Ajmaline

Zoom

Cat No: 29962

Biochemicals - Ion Channel Modulation

Ajmaline is an alkaloid that has been found in R. serpentina and has ion channel inhibitory and antiarrhythmic activities.{46769,46770,46771,46772,46773} It inhibits the human-ether-a-go-go (hERG) potassium channel, also known as Kv11.1, and the volta...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

(17R,21?)-ajmalan-17,21-diol

Correlated keywords:

NSC15627 Ajmalin Cardiorythmine Gilurytmal Ignazin Merabitol Rauvolfia Kv-11.1 1.5 4.3

Product Overview:
Ajmaline is an alkaloid that has been found in R. serpentina and has ion channel inhibitory and antiarrhythmic activities.{46769,46770,46771,46772,46773} It inhibits the human-ether-a-go-go (hERG) potassium channel, also known as Kv11.1, and the voltage-gated potassium channel subtypes Kv1.5 and Kv4.3 with IC50 values of 42.3, 293, and 186 µM, respectively, in Xenopus oocytes expressing the channels.{46770,46771} Ajmaline (1 µg/ml) increases the action potential duration in isolated dog atrium and ventricle.{46772} It increases the functional refractory duration in the atrium, ventricle, and atrioventricular conduction system in anesthetized dogs when administered intravenously at a dose of 1 mg/kg.{46772} Ajmaline (2 mg/kg, i.v.) reduces the number of premature ventricular complexes and decreases the duration of ventricular tachycardia and ventricular fibrillation in coronary artery-ligated anesthetized rats.{46773}

Size	50 mg
Shipping	dry ice
CAS Number	07/12/4360 00:00
Molecular Formula	C₂₀H₂₆N₂O₂
SMILES	CN1C2=C(C=CC=C2)C3([C@H](O)[C@]45[H])C[C@]4([H])N6[C@H](O)[C@@H](CC)[C@]5([H])C[C@@]6([H])[C@@]31[H]
Molecular Weight	326,4
Formulation	A crystalline solid
Purity	≥95%
Custom Code	2939.79
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.